Consultant

Dr Ilaria Testi

Consultant Ophthalmologist
MD
Headshot of Consultant Ilaria Testi, Ophthalmologist

Dr Ilaria Testi is a Consultant Ophthalmologist based in London, specialised in Uveitis and Inflammatory Eye Diseases. She manages uveitis in adults and children with over 10 years鈥� experience in ocular inflammatory diseases, gained from international training and work experience.

Ophthamology
English, Italian
In-person, Phone call, Video call
New 拢300 (follow-up 拢220)

Bio

Dr Ilaria Testi trained in Ophthalmology at the University of Padova, Italy. She undertook international training in Uveitis and Ocular Inflammatory Diseases at Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India and Tan Tock Seng Hospital, Singapore. She completed two fellowships in Uveitis and Ocular Inflammation at Moorfields Eye Hospital, London. She trained in Paediatric Uveitis at Great Ormond Street Hospital for Children, London. She is currently a MPH degree candidate at the London School of Hygiene and Tropical Medicine (Master Degree in Public Health).

Dr Ilaria Testi currently works as NHS Consultant Ophthalmologist within the Uveitis Service at Moorfields Eye Hospital, and the Paediatric Uveitis Service at Great Ormond St Hospital, managing uveitis and inflammatory eye diseases in adults and children. Ilaria is also the Clinical Lead of the Uveitis Virtual Service at Moorfields Eye Hospital.

Dr Ilaria Testi has delivered more than 50 invited lectures and participated in several instruction courses at various national and international meetings. She has a strong interest in clinical and medical research, and has been prolific to share her scientific work through numerous manuscripts published in the literature. She has authored more than 60 publications in peer-reviewed scientific journals and book chapters. Her primary area of research interest includes ocular inflammatory diseases (uveitis, scleritis), inflammatory eye diseases in adults and children, ocular infections, including ocular tuberculosis, herpes disease and ocular toxoplasmosis, multimodal imaging in uveitis, and treatment with immunosuppressive and biological agents. Dr Ilaria Testi serves on the Editorial Board and is Associate Editor for several journals, including 鈥楯ournal of Ocular Infections and Inflammation鈥� and 鈥業nflammatory Eye Diseases for Frontiers in Ophthalmology鈥�.

More information

  • Medical School, University of Padova, Italy
  • Department of Ophthalmology, University of Padova, Italy
  • Uveitis Service, Advanced Eye Centre, PGIMER, Chandigarh, India
  • Department of Uveitis, NH Group Eye Institute, Tan Tock Seng Hospital, Singapore
  • Department of Uveitis and Scleritis, Moorfields Eye Hospital NHS Foundation Trust, London, UK
  • Paediatric Uveitis Service, Department of Rheumatology, Great Ormond Street Hospital for Children, London, UK
  • London School of Hygiene and Tropical Medicine, London, UK
  • Dr Testi's private practice is based at AOA体育平台 Eye Centre, 119 Harley Street London W1G 6A
  • Consultant Ophthalmologist, Department of Uveitis, Moorfields Eye Hospital NHS Foundation Trust, London
  • Consultant Ophthalmologist, Paediatric Uveitis Service, Department of Rheumatology, Great Ormond Street Hospital for Children NHS Foundation Trust, London 
  • Clinical Lead of the Uveitis Virtual Service, Moorfields Eye Hospital NHS Foundation Trust, London
  • Adult and Paediatric Uveitis
  • Infectious and Non-Infectious Uveitis
  • Anterior, Intermediate, Posterior and Panuveitis
  • Retinal Vasculitis, Retinitis and Choroiditis
  • Bechet鈥檚 Disease
  • Birdshot Retinochoroiditis
  • Sarcoidosis
  • Juvenile Idiopathic Arthritis associated Uveitis
  • Viral uveitis
  • Ocular Tuberculosis
  • Ocular Toxoplasmosis
  • Ocular Syphilis
  • Episcleritis and Scleritis
  • Endophthalmitis
  • Ocular multimodal imaging (optical coherence tomography, angiography)
  • Immunosuppressive and biological agents
  • Anti-inflammatory local therapy

Dr Ilaria Testi is a member of various professional organizations, societies and study groups, including:

  • The General Medical Council (GMC)
  • IOIS (International Ocular Inflammation Society)
  • Paediatric Ocular Inflammation Group (POIG)
  • UCL-TB (University College London Tuberculosis)
  • Collaborative Ocular Tuberculosis Study Group (COTS)
  • Comprehensive Ocular Imaging Network (COIN)
  • Infectious Uveitis Treatment Algorithm Network (TITAN)
  • COVID-19 Vaccination Ocular Inflammatory Events Study Group
  • SIUMIO (Societ脿 Italiana Uveiti e Malattie Infiammatorie Oculari).

Dr Ilaria Testi has a strong interest in medical research, and has been prolific to share her scientific work through numerous manuscripts published in the literature. She has authored more than 60 publications in peer-reviewed scientific journals and book chapters. Her primary area of research interest includes ocular inflammatory diseases (uveitis, scleritis), inflammatory eye diseases in adults and children, ocular infections, and treatment with immunosuppressive and biological agents.

  1. Testi I, Soomro T, Pavesio C, Solebo AL. Ocular inflammatory events following COVID-19 vaccination: reporting of suspected adverse drug reactions to regulatory authorities in the UK. Br J Ophthalmol. 2024 Jan 22:bjo-2023-324503. 
  2. Thng ZX, Putera I, Testi I, et al; TITAN consensus guidelines group. The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 1-global current practice patterns for the management of Herpes Simplex Virus and Varicella Zoster Virus anterior uveitis. Eye (Lond). 2024 Jan;38(1):61-67.
  3. Testi I, Brand茫o-de-Resende C, De-La-Torre A, et al. Ocular Inflammatory Events Following COVID-19 Vaccination in the Paediatric Population: A Multinational Case Series. Ocul Immunol Inflamm. 2023 Jun 14:1-6.
  4. Testi I, Calcagni A, Barton K, Gooch J, Petrushkin H. Hypotony in uveitis: an overview of medical and surgical management. Br J Ophthalmol. 2022 Dec 20:bjo-2022-322814.
  5. Betzler BK, Putera I, Testi I, et al. Anti-tubercular therapy in the treatment of tubercular uveitis: A systematic review and meta-analysis. Surv Ophthalmol. 2023 Mar-Apr;68(2):241-256.
  6. Goh EJH, Putera I, La Distia Nora R, Mahendradas P, Biswas J, Chee SP, Testi I, Pavesio CE, Curi ALL, Vasconcelos-Santos DV, Arora A, Gupta V, de-la-Torre A, Agrawal R. Ocular Toxoplasmosis. Ocul Immunol Inflamm. 2022 Sep 12:1-20.
  7. Singh RB, Perepelkina T, Testi I, Yet al. Imaging-based Assessment of Choriocapillaris: A Comprehensive Review. Semin Ophthalmol. 2022 Aug 18:1-22.
  8. Agrawal R, Ludi Z, Testi I, et al. The Collaborative Ocular Tuberculosis Study (COTS) calculator-a consensus-based decision tool for initiating antitubercular therapy in ocular tuberculosis. Eye (Lond). 2022 Jun 28.
  9. Testi I, Brand茫o-de-Resende C, Agrawal R, Pavesio C; COVID-19 Vaccination Ocular Inflammatory Events Study Group. Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect. 2022 Jan 4;12(1):4.
  10. Modugno RL, Testi I, Pavesio C. Intraocular therapy in noninfectious uveitis. J Ophthalmic Inflamm Infect. 2021 Oct 10;11(1):37. 11. Testi I, Modugno RL, Pavesio C. Multimodal imaging supporting the pathophysiology of white dot syndromes. J Ophthalmic Inflamm Infect. 2021 Oct 22;11(1):32.
  11. Testi I, Vermeirsch S, Pavesio C. Acute posterior multifocal placoid pigment epitheliopathy (APMPPE). J Ophthalmic Inflamm Infect. 2021 Nov 1;11(1):31.
  12. Testi I, Aggarwal K, Jaiswal et al. Antiviral Therapy for Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV)-Induced Anterior Uveitis: A Systematic Review and Meta-Analysis. Front. Med. 2021 July 2;8:686427.
  13. Ajamil-Rodanes S, Testi I, Luis J, Robson AG, Westcott M, Pavesio C. Evaluation of fluocinolone acetonide 0.19 mg intravitreal implant in the management of birdshot retinochoroiditis. Br J Ophthalmol. 2020 Nov 26:bjophthalmol-2020-317372.
  14. Agrawal R, Testi I, Rousselot A, et al. Insights into the molecular pathogenesis of ocular tuberculosis. Tuberculosis (Edinb). 2020 Nov 12;126:102018.
  15. Testi I, Betzler B, Gupta V, Kon OM, Agrawal R, Pavesio C. Current clinical management of ocular tuberculosis, Expert Review of Ophthalmology. 2020;15:2, 93-99.
  16. Testi I, Agrawal R, Mehta S, Basu S, Nguyen Q, Pavesio C, Gupta V. Ocular tuberculosis: Where are we today? Indian J Ophthalmol. 2020 Sep;68(9):1808-1817.
  17. Testi I, Agrawal R, Mahajan S, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Descriptive Review of Tubercular Uveitis in Paediatric Population. Ocul Immunol Inflamm. 2020 Aug 17:1-7.
Share

Contact us

Request an appointment with our world-leading consultants today, or speak to our helpful advisors for tailored advice.